Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report

Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report

Background: We present an interesting case of bilateral retinitis pigmentosa (RP)-associated cystoid macular oedema that responded on two separate occasions to intravitreal injections of aflibercept, despite previously demonstrating only minimal response to intravitreal ranibizumab. This unique case...

Full description

Bibliographic Details
Main Authors: Stacey A. Strong, Avinash Gurbaxani, Michel Michaelides
Format: Article
Language:English
Published: Karger Publishers 2016-09-01
Series:Case Reports in Ophthalmology
Subjects:
Aflibercept
Eylea
Retinitis pigmentosa
Cystoid macular oedema
Online Access:http://www.karger.com/Article/FullText/448427

Internet

http://www.karger.com/Article/FullText/448427

Similar Items